Monday, 16 July 2018

  • it
  • en

Research & Development

Results of the first joint transnational call

The EuroNanoMed ERA-net has decided to support innovative research and development projects, corresponding to a total project cost of 17 M€. 8 transnational projects will be supported in the EuroNanoMed first call for proposals, corresponding to a success rate of 44%. The call was launched to promote collaborative and interdisciplinary research consortia.

EuroNanoMed was created to bridge the gap between academic research and industries as well as clinical applications. This is expected to shorten the time from research results to the clinical and/or industrial application for the benefit of the patient. In May 2009, a first joint call for proposals opened to all key players in each of the 18 partner regions/countries. The call focused on the three main subfields of Nanomedicine: diagnostics, targeted delivery and regenerative medicine. The applications were evaluated by external reviewers and a final ranking list was established by a peer review panel. The global assessment i.e. scientific, technical, translational and/or commercial potential decided the allocation of funds by the EuroNanoMed consortium.

The chair of the international peer review panel, Professor Frank Barry, points to the high quality of the selected projects, their international competitiveness and their innovative potential.
- "The projects address very significant medical needs with high quality science and
technology and will develop an industrial vision for new and effective patient applications", says Professor Barry.

Download the press release: press_release_JTC1_Final_20.pdf

Co-funded Project by:

Unione Europea

Repubblica Italiana

Regione Veneto

©2010-2016 Veneto Nanotech ScpA in liq.
SEDE LEGALE: Piazza Salvemini, 13 I-35131 Padova - Italy
SEDE AMMINISTRATIVA: c/o CNR, Corso Stati Uniti, 4 I-35127 Padova - Italy
Tel. +39 331 7413295
C.F., iscrizione Reg. Imprese e P.IVA 03845260284